dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
oprasta 5mg/100ml soln. for inf. 100 ml
اوبراستا 5مجم/100مل محلول وريدي 100 مل
zoledronic acid · 5mg/100ml
1582EGP
Available
Active ingredient
zoledronic acid
Strength
5mg/100ml
Form
solution
Manufacturer
pharco
Route
injection

Uses

Used for osteoporosis in postmenopausal women and men, prevention of glucocorticoid-induced osteoporosis, and Paget's disease of bone.

Do not use if

Contraindicated in hypocalcemia, severe renal impairment, and hypersensitivity to zoledronic acid or its components.

Side effects

Common effects include fever, muscle pain, headache, joint pain, nausea, and flu-like symptoms.

Warnings

Monitor calcium levels and renal function. Adequate calcium and vitamin D supplementation is usually required.

How it works

A bisphosphonate that inhibits osteoclast-mediated bone resorption, increasing bone density and reducing fracture risk.

Storage

Store at 20–25°C. Protect from extreme temperatures.